POLITICSMay 18 · 09:00 UTCKFF HEALTH NEWSDarius Tahir

Trump Bought Stock in Drugmaker as His Government Boosted Its Obesity Drugs

President Donald Trump bought stock in Eli Lilly, a drugmaker, as his government made decisions benefiting the company's obesity drugs business. The purchases coincided with favorable government decisions, including progress toward Medicare reimbursement for the drugs. Trump's investments were valued up to $680,000.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned

Donald TrumppersonEli LillyorganizationCenters for Medicare & Medicaid ServicesorganizationMedicaretopicWest Pharmaceutical ServicesorganizationDepartment of Health and Human Servicesorganization

Spot something wrong with this article?Report a problem →

Forward this